Spartin Promotes Smurf1‐Mediated Ubiquitination Modification of YWHAZ to Inhibit Cisplatin Resistance in Ovarian Cancer
The FASEB Journal · 2025
DOI: 10.1096/fj.202401164r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Jun Yin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, The Affiliated Shunde Hospital of Jinan University, Foshan, Guangdong Province, P.R. China. Hauptthemen laut MEDLINE: Cisplatin, 14-3-3 Proteins, Drug Resistance, Neoplasm, Ubiquitin-Protein Ligases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Beijing Bethune Public Welfare Foundation, Natural Science Foundation of Xinjiang Uygur Autonomous Region.
Abstract (Originalsprache)
Cisplatin (DDP) remains the commonly used chemotherapeutic drug for ovarian cancer (OV); however, DDP resistance poses a great challenge to the outcomes of patients. This work investigated the biological function and mechanism of Spartin in DDP resistance of OV. The growth and apoptosis of DDP‐resistant OV cells were assessed by CCK‐8, colony formation, and flow cytometry, respectively. Autolysosome fusion was observed by immunofluorescent staining of LC3 and LAMP2. The interaction between E3 ligase Smurf1 and YWHAZ or Spartin protein, and the ubiquitination level of YWHAZ were determined by Co‐IP assay. Expression levels of autophagy or apoptosis‐related markers were measured by RT‐qPCR, western blotting, and immunohistochemistry. DDP resistance was assessed by xenograft tumor experiments in vivo. We found that Spartin expression was lower, while YWHAZ expression was higher in DDP‐resistant OV samples and cells. Lower expression of Spartin indicated a poorer survival rate of OV patients. In addition, overexpression of Spartin sensitized OV cells to DDP and repressed autophagy. Moreover, Spartin bound to Smurf1 to promote Smurf1‐mediated ubiquitination and degradation of YWHAZ, restraining autophagy and DDP resistance. Overexpression of YWHAZ counteracted the effects of Spartin against DDP resistance by promoting autophagy. In conclusion, Spartin‐induced Smurf1‐mediated ubiquitination modification of YWHAZ to inactivate autophagy, thereby increasing the sensitivity of OV cells to DDP. Our findings suggest that Spartin‐combined therapy might act as an effective approach to fight against DDP resistance in OV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, The Affiliated Shunde Hospital of Jinan University, Foshan, Guangdong Province, P.R. China.
- Department of Gynecology, Affiliated Tumor Hospital of Xinjiang Medical University, Xinjiang Uygur Autonomous Region, P.R. China.
- Department of Pharmaceutics, Chongqing University Jiangjin Hospital, Chongqing, P.R. China.
- Department of Pediatrics, Chongqing University Jiangjin Hospital, Chongqing, P.R. China.
- Oncology, Chongqing University Jiangjin Hospital, Chongqing, P.R. China.
ORCID-Profile: Jun Yin, Jing Huang
Förderung
- Beijing Bethune Public Welfare Foundation
- Natural Science Foundation of Xinjiang Uygur Autonomous Region
Zitieren
APA
Yin, J., Ma, Y., Fu, H., Fan, Y., Xiang, D., Ding, L., & Huang, J. (2025). Spartin Promotes Smurf1‐Mediated Ubiquitination Modification of YWHAZ to Inhibit Cisplatin Resistance in Ovarian Cancer. The FASEB Journal. https://doi.org/10.1096/fj.202401164r
Vancouver
Yin J, Ma Y, Fu H, Fan Y, Xiang D, Ding L, et al. Spartin Promotes Smurf1‐Mediated Ubiquitination Modification of YWHAZ to Inhibit Cisplatin Resistance in Ovarian Cancer. The FASEB Journal. 2025. doi:10.1096/fj.202401164r
BibTeX
@article{Yin2025,
author = {Yin, Jun and Ma, Yan and Fu, Hong and Fan, Ying and Xiang, Debing and Ding, Ling and Huang, Jing},
title = {Spartin Promotes Smurf1‐Mediated Ubiquitination Modification of YWHAZ to Inhibit Cisplatin Resistance in Ovarian Cancer},
journal = {The FASEB Journal},
year = {2025},
doi = {10.1096/fj.202401164r}
}
EUVIMED